Cerebrolysin
Overview
Research-use peptide and amino-acid preparation supplied for studies of neurotrophic signaling, neuronal survival, and CNS pathway models.
- Concentration
- 30 mg
- Stock
- In stock
Product details
Cerebrolysin is a peptide and amino-acid preparation derived from enzymatically processed porcine brain proteins and used in neurotrophic-signaling research models. Pattern lists this material for controlled laboratory research.
Research Targets: Neurotrophic signaling networks, neuronal survival pathways, synaptic plasticity mechanisms, neuroinflammatory and oxidative-stress response systems.
Key Feature: Multi-component peptide and amino-acid preparation for CNS pathway research.
Research Focus Areas: Neuroprotection models, neuronal regeneration pathway studies, synaptogenesis, CNS injury model signaling.
Common Models: Primary neuronal culture assays, neurite outgrowth studies, rodent CNS injury models, neurodegeneration model systems.
Mechanistic Interests: PI3K/Akt signaling, MAPK pathway modulation, mitochondrial stress markers, synaptic remodeling, excitotoxic stress response.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Research context
Peptide guide
Open full guide- Guide profile
- Porcine Brain-Derived Neurotrophic Peptide Mixture
- Composition
- Mixture of low-molecular-weight peptides and amino acids produced from purified porcine brain proteins.
- Discovery
- Developed as a neuropeptide preparation for neurologic disorders and used in parts of Europe, Asia, and other regions
- Research scope
- The evidence base is broader than many research peptides but remains mixed; systematic reviews in acute ischemic stroke have found uncertain or limited clinically meaningful benefit for major outcomes
- Regulatory status
- Region-specific medical use; not FDA-approved
Safety context
- Known hypersensitivity to Cerebrolysin or porcine-derived components
- Epilepsy or seizure disorders without clinician guidance
- Severe renal impairment is commonly listed as a caution/contraindication in product labeling
Research-use notice: Cerebrolysin is a prescription neuropeptide mixture in some countries but is not FDA-approved in the United States. Evidence is mixed and indication-specific.
Full guide includes 10 reference entries.
One kit adds 10 vials to checkout.